GMAB
Genmab·NASDAQ
--
--(--)
--
--(--)
7.38 / 10
Outperform
Fundamental evaluation is encouraging with a 7.4/10 score. Core strengths include a healthy interest-coverage ratio (EBIT/Interest expense) of 15.48, indicating solid interest-payment capacity, and robust revenue momentum with Total Operating Revenue growing 21.11 YoY. Growth is complemented by positive Profit-MV and Cash-MV metrics. However, a high Days Sales Outstanding of 99.86 suggests potential inefficiencies in receivable collection, and PB-ROE at 1.85 places the stock in a higher valuation quartile. These factors collectively justify an Outperform stance with a note of caution on working-capital management.
Analysis Checks(9/10)
Revenue-MV
Value-0.59
Score3/3
Weight16.56%
1M Return10.54%
Value-0.59
Score3/3
Weight16.56%
1M Return10.54%
Days sales outstanding
Value99.86
Score0/3
Weight-5.85%
1M Return-5.18%
Value99.86
Score0/3
Weight-5.85%
1M Return-5.18%
Net income-Revenue
Value1.19
Score3/3
Weight15.71%
1M Return9.29%
Value1.19
Score3/3
Weight15.71%
1M Return9.29%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.32%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.32%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight24.48%
1M Return13.15%
Value-0.50
Score3/3
Weight24.48%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value21.11
Score2/3
Weight1.41%
1M Return1.11%
Value21.11
Score2/3
Weight1.41%
1M Return1.11%
Profit-MV
Value0.93
Score2/3
Weight13.20%
1M Return8.45%
Value0.93
Score2/3
Weight13.20%
1M Return8.45%
PB-ROE
Value1.85
Score2/3
Weight16.47%
1M Return9.14%
Value1.85
Score2/3
Weight16.47%
1M Return9.14%
Operating revenue (YoY growth rate %)
Value21.11
Score2/3
Weight0.54%
1M Return0.43%
Value21.11
Score2/3
Weight0.54%
1M Return0.43%
Cash-MV
Value0.27
Score3/3
Weight18.79%
1M Return9.67%
Value0.27
Score3/3
Weight18.79%
1M Return9.67%
Revenue-MV
Value-0.59
Score3/3
Weight16.56%
1M Return10.54%
Value-0.59
Score3/3
Weight16.56%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value21.11
Score2/3
Weight1.41%
1M Return1.11%
Value21.11
Score2/3
Weight1.41%
1M Return1.11%
Days sales outstanding
Value99.86
Score0/3
Weight-5.85%
1M Return-5.18%
Value99.86
Score0/3
Weight-5.85%
1M Return-5.18%
Profit-MV
Value0.93
Score2/3
Weight13.20%
1M Return8.45%
Value0.93
Score2/3
Weight13.20%
1M Return8.45%
Net income-Revenue
Value1.19
Score3/3
Weight15.71%
1M Return9.29%
Value1.19
Score3/3
Weight15.71%
1M Return9.29%
PB-ROE
Value1.85
Score2/3
Weight16.47%
1M Return9.14%
Value1.85
Score2/3
Weight16.47%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.32%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.32%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value21.11
Score2/3
Weight0.54%
1M Return0.43%
Value21.11
Score2/3
Weight0.54%
1M Return0.43%
Asset-MV
Value-0.50
Score3/3
Weight24.48%
1M Return13.15%
Value-0.50
Score3/3
Weight24.48%
1M Return13.15%
Cash-MV
Value0.27
Score3/3
Weight18.79%
1M Return9.67%
Value0.27
Score3/3
Weight18.79%
1M Return9.67%
Is GMAB undervalued or overvalued?
- GMAB scores 7.38/10 on fundamentals and holds a Discounted valuation at present. Backed by its 17.12% ROE, 0.00% net margin, 13.37 P/E ratio, 3.45 P/B ratio, and 118.66% earnings growth, these metrics solidify its Outperform investment rating.
